Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Erlotinib, Radiation Therapy, and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck

NCT00442455 is registered in ClinicalTrials.gov with Grupo de Investigación Clínica en Oncología Radioterapia as lead sponsor.

NCT NCT00442455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00442455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Erlotinib, Radiation Therapy, and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck
Lead sponsor
Grupo de Investigación Clínica en Oncología Radioterapia
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
August 31, 2015
Enrollment
53 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the head and neck